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The human erythrocyte membrane contains three  sialoglycoproteins which 
can be distinguished by electrophoresis on acrylamide gels in the presence of 
sodium dodecyl sulfate (SDS) 1 (1,  2)  2. They appear to extend from the outer 
surface through the membrane barrier to the interior surface (2, 3). Recently, it 
was shown that these sialoglycoproteins can be solubilized and recovered almost 
quantitatively in the aqueous phase after extraction of red cell ghosts with a 
mixture of chloroform and methanol? In the present report, the preparation of 
the major glycoprotein, the so-called MN glycoprotein (4-10), from the aqueous 
phase of chloroform-methanol extracts is described. The partial characterization 
of  this  membrane glycoprotein includes the  analysis by  SDS-acrylamide gel 
electrophoresis, determination of  carbohydrate and  amino acid compositions, 
assays of inhibitory activities for hemagglutination by rabbit M- and N-anti- 
sera, influenza virus and Phaseolus vulgaris phytohemagglutinin, and assays of 
its inhibitory activities in various lymphocyte stimulation systems. 
Materials and Methods 
All chemicals employed in these studies were reagent grade. Protein concentrations were 
determined by the method of Lowry et al. (11) using bovine pancreatic ribonuclease (Worth- 
ington Biochemical Corp., Freehold, N. J.) as standard. The microhiuret method was carried 
out according to Goa (12). Cholesterol was measured by the method of Zlatkis et al. (13), and 
phosphorus was assayed by the technique of Bartlett (14). Sialic acid was determined by the 
method described by Warren (15) after hydrolysis in 0.1 g HzSO4 at 80°C fol  1 hr. Hexoses 
were determined with the  orcinol  method as described by Vasseur (16). Galactose-mannose 
ratios were obtained after chromatographic separation according to Spiro (17). Hexosamines 
were measured with Svennerholm's modification (18) of the Elson-Morgan reaction; galactosa- 
* Supported by U.S. Public Health Service Grant AM 11796, and aided by a grant from 
the National Foundation March of Dimes. 
:~ This wink was presented in part at the 4th International Congress of Human Genetics, 
Paris, 4-11 September 1971. 
1  Abbreviations used in  this paper: CM,  chloroform-methanol; GP,  glycoprotein;  PAS, 
periodic acid-Schiff;  PHA, phytohemagglutinin; SDS, sodium dodecyl sulfate. 
2 Hamaguchi, H., and H.  Cleve. 1972. Solubilization of  human  erythrocyte  membrane 
glycoproteins and separation of the MN glycoprotein from a glycoprotein with I, S and A 
activity. Biochim. Biophys. Aeta. 278:271. 
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mine was assayed by the method of Ludowieg and Benmaman (19). Fucose was measured with 
a semimicro modification of the method of Dische and Shettles (20). For the chemical analyses 
the freeze-dried, purified MN glycoprotein was weighed in with a  Cahn M  I0 electrobalance 
(Cahn Instruments, Paramount, Calif.). Amino acid analysis was performed on a  Beckman 
Model 120-B  automatic amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.) 
using the system of Moore and Stein (21).  The protein was hydrolyzed in evacuated sealed 
tubes in 6 M HC1 at ll0°C for 22 hr. Methionine was determined after performic acid oxidation 
according to Moore (22).  The least-square numerical method devised by Katz (23) was used 
for calculating the minimal molecular weight from the amino acid analysis data. 
SDS-acrylamide gel electrophoresis was carried out in 1%  SDS-7.5% acrylamide gels as 
described previously (24). ~ The gels were stained with Coomassie brilliant blue (24) or with 
the periodic acid-Schiff (PAS) reagent according to Zacharius et al. (25). 
Blood group activities and activities for myxovirus and phytohemagglutinin receptor sites 
were  measured  by  hemagglufination inhibition  tests.  Twofold  serial  dilutions of  antigen- 
containing materials  were  tested;  the  specific inhibitory activities were  calculated  as  the 
smallest amount of material necessary to inhibit completely hemagglutination at four hemag- 
glutinating units of  reagent.  The  quantities were  expressed  in  micrograms of protein per 
milliliter according to the values found with the Folin method of Lowry et al.  (11).  Rabbit 
antisera for M  and N, and human antisera for A and B, were purchased from Behring Diag- 
nostics Inc. (Woodbury, N. Y.). For assay of phytohemagglutinin inhibitory activity, PHA-P 
(Difco Laboratories, Detroit, Mich.) from Phaseolus vulgaris  was used. The spot test described 
by Kornfeld and Kornfeld (26) was employed. Inhibition of myxovirus hemagglutination was 
determined according to Kathan et al.  (4).  RI/5+  strain of influenza virus A2 was kindly 
provided by Dr. Purnell W. Choppin, The Rockefeller University, New York. 
Inhibition of the mitogenic response of lymphocytes to various phytohemagglutinins was 
determined by measuring the incorporation of thymidine-~H into DNA by lymphocytes in 
short-term cultures to which different amounts of purified MN glycoproteins had been added. 
1 ml cultures containing 0.2  >(  106 mononuclear cells placed in 13  X  100 mm tissue culture 
tubes  (Falcon Plastics, Oxnard,  Calif.) were used.  Mter 72 hr,  thymidine-3H incorporation 
was measured according to Hughes and Caspary (27). Phaseolus  vulgarls  phytohemagglutinins 
PHA-P  (Difco Laboratories,  lot No.  550120)  and purified phytohemagglutinin  (Welleome 
Research Laboratories, Beckenham, England, lot No.  K.  1360)  were used in concentrations 
of  50 #g/ml  and  0.5  #g/ml,  respectively.  Concanavalin A  (K  and  K  Laboratories,  Inc., 
Plainview, N. Y., lot No.  27646)  was added at 10 #g/ml. 
RESULTS 
Preparation of MN Glycoprotein.--150-250  ml of human  blood tom  individ- 
ual  donors,  collected  in  acid-citrate-dextlose  and no more  than  2  wk  old,  was 
used for the preparation of erythrocyte membranes. 
Plasma and buffy coat were removed and cells were washed three times with 0.3 ~t dextrose 
by centrifugation at +4°C for 15 rain at 2000 g. Cells were lysed with 9 vol of distilled water 
and ghosts were sedimented at 12,000 g for 20 rain. The ghosts were washed four times with 10 
m~ tris(hydroxymethyl)aminomethane(Tris)-0.1 m~ ethylenediaminetetraacetate (EDTA), 
pH 7.4,  by centrifugation at 25,000  g for 30 min. Glycoproteins were extracted according to 
Kornfeld  and  Kornfeld  (26)  as  described  in detail elsewhere. ~ To  1 vol of packed  ghosts 
suspended in Tris-EDTA buffer, 9 vol of a mixture of chloroform-methanol (2:1, v/v) weie 
added with vigorous shaking of the flask. The mixture was stirred for 30 min at room tempera- 
ture and centrifuged afterwards for 10 min at 1000 g. The aqueous phase was carefully aspirated, 
centrifuged again in order to remove contaminating interphase components, and concentrated 1142  MN  GLYCOPROTEINS OF  HUMAN ERYTItROCYTE MEMBRANES 
to approximately one-fifth of the volume of the original ghost suspension. The aqueous phase 
of the chloroform-methanol (CM) extracts was, after reduction and alkylation, fraetionated 
further by gel filtration on Sepharose 4B (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) 
columns in the presence of 6 ~  guanidine hydrochloride (28). To the aqueous phase of CM 
extracts an equal weight of guanidine hydrochloride was added. Disulfide bonds were reduced 
by fl-mercaptoethanol for 4 hr and alkylation was carried out with 0.1 M  iodoacetic acid in the 
presence of 0.3 ~ Tris for 1 hr. The solution remained clear throughout  this procedure. The 
reduced and alkylated material was applied with 10% (w/v) sucrose to Sepharose 4B columns 
prepared with 6 M guanldine hydrochloride; two different sizes were used: 5 cm in diameter 
and 80 cm in length, or 2.5 cm in diameter and 80 cm in length, respectively. The columns 
were calibrated with purified polypeptide chains of known molecular weights. 
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FIG. t.  Gel filtration on Sepharose 4B in 6 M  guanidine hydrochloride. O .....  O, elution of 
reduced and alkylated human erythrocyte ghost proteins. •--  •, elution of human erythro- 
cyte membrane glycoproteins from aqueous phase after chloroform-methanol extraction. 
Fig.  1  demonstrates a  representative elution diagram.  The proteins of  the 
aqueous phase  of  CM  extracts  are  separated  into two  fractions. The elution 
pattern of total human erythrocyte ghost proteins on this column is given for 
comparison (Fig. 1, dotted line). The ghosts were solubilized with 6 M guanidine 
hydrochloride according to Gwynne and Tanford (28). The red cell ghost pro- 
teins were separated into five major fractions. The fractions of the two peaks 
from the aqueous phase of CM extracts were pooled as indicated, dialyzed for 4 
days at +4°C against distilled water, and subsequently  concentrated by vacuum 
ultrafiltration. Analysis of these two fractions were carried out by SDS-poly- 
acrylamide gel electrophoresis (Fig. 2). The aqueous phase of CM extracts con- 
tains the glycoproteins GP I, GP II, and GP III and the glycoprotein compo- 
nent  B  as  demonstrated  previously.  2  The  first  peak  from  the  Sepharose 
4B-guanidine hydrochloride column is composed of several proteins: some high HARTWIG  CLEVE,  HIDEO  HAMAGUCIII~  THOMAS IYUTTEROTH  1143 
molecular weight components penetrate the  gel only a  few millimeters; these 
components may represent aggregated glycoproteins. One component migrates 
slightly slower than GP I; there is also a limited amount of GP I. In addition, 
substantial amounts of GP II and a fair amount of GP III are found. The second 
peak contains  a  single component.  Although  this  material is  eluted  from the 
column late, that is at an effluent volume of approximately 250 ml, this glyco- 
protein  GP  I  migrates  relatively slowly on  SDS-polyacrylamide gel  electro- 
phoresis. In the majority of preparations, the second peak contained only this 
single component. In the remainder of preparations,  this peak contained very 
FIG. 2.  Electrophoresis on  1% SDS-7.5% acrylamide gels. 1-3  stained by  Coomassie 
brilliant blue: (1)  aqueous phase of chloroform-methanol extracts,  (2)  fraction I  from gel 
filtration on Sepharose  4B in 6 ~t guanidine hydrochloride, (3) fraction II from gel filtration on 
Sepharose 4B  in 6 •  guanidine hydrochloride. 4-6 stained by periodic acid-Schiff (PAS): 
(4) aqueous phase, (5) fraction I, (6) fraction II. GP, glycoprotein; GP I, II, and III refer to 
the three glycoproteins  present in the aqueous phase of chloroform-methanol  extracts. 
small  amounts of contaminating  GP II and  GP  III which  could be disclosed 
when large amounts of protein (80 #g) were applied to the gels. Purity of these 
preparations was tested also by polyacrylamide gel electrophoresis without SDS 
in  the  presence  of 8  M urea,  and  by electrophoresis  on  5 %  acrylamide gels, 
without SDS and without urea, using a 5 m~ Tris-38 m~ glycine buffer, pH 8.3, 
both as gel buffer and as electrode buffer (24).  With both systems single compo- 
nents  were  observed  which,  however,  ga~e  slightly  blurred  patterns  at  the 
cathodal end of the protein band while the anodal front of the protein bands was 
sharply defined. 
The recovery of purified  GP  I, the  so-called MN  glycoprotein,  was on  the 
average approximately 5 mg of purified and freeze-dried protein/150 ml blood. 
It was noticed that the procedure could not be scaled up easily since the capacity 1144  MN  GLYCOPROTEINS  OF  HUMAN  ERYTHROCYTE  MEMBRANES 
of the Sepharose 4B-6 M guanidine hydrochloride column appeared to be rather 
limited. Application of larger amounts of proteins from the  aqueous phase of 
of CM extracts did not lead to higher yields of purified MN glycoprotein but to 
an increase of the first peak which contained relatively large amounts of GP I 
which were disporprotionately increased, than when smaller quantities of pro- 
tein were applied to the column. 
Analysis of MN Glycoprotein.--The chemical composition of three MN glyco- 
protein prepalations is shown in Table I. Results are given in grams per 100 g 
dry weight of purified freeze-dried MN glycoprotein. The results of one prepara- 
tion from each genotype, MlVl, MN, and NN, are presented. The material con- 
tains  approximately 40%  protein.  It  is  noteworthy  that  the  determination 
with the phenol reagent of Folin and Ciocalteau gave consistently lower pro- 
tein  estimates  than  the  determination  with  the  biuret  reaction.  Approxi- 
mately 40-50%  of the material is  carbohydrate; approximately 20%  of the 
TABLE I 
Chemical Composition oJ Human Erythrocyte Membrane Glycoproteins MM, MN, and NN 
Constituent  MM  MN  NN 
~;/100 g  g/lO0  g  g/lO0 g 
Protein (biuret)  38.5  43.0  38.5 
Protein (folin)  25.0  26.5  25.5 
Sialic acid  17.2  23.4  20.5 
Hexosamine  7.9  10.3  7.4 
Hexose  10.8  13.7  12.3 
Fucose  0.74  0.74  0.60 
Phosphorus  0.621  0.120  0. 258 
total is  sialic  acid. Traces of phosphorus were detected indicating that these 
preparations contain phospholipids despite preceding extraction by chloroform- 
methanol, subsequent treatment with 6 M guanidine hydrochloride, and separa- 
tion by gel filtration on Sepharose 4B-guanidine hydrochloride columns. The 
phospholipid content may vary from approximately 20% in the MM prepara- 
tion to less than 10% in the MN preparation (Table I). Further carbohydrate 
analysis showed galactosamine concentrations in the MM, MN, and NN prep- 
arations of 3.2, 6.4, and 3.4 g/100 g, respectively. The galactose/mannose ratios 
in the MM, MN, and NN preparations were found to be 3.0, 7.5, and 6.9, respec- 
tively. 
In Fig. 3 the patterns on 1% SDS-7.5 % polyacrylamide gel electrophoresis 
are shown. Differences in eleetrophoretic migration rates of the purified glyco- 
proteins of types MM, MN, and NN are not revealed. Fig. 3 also illustrates the 
varying degrees of purity of different preparations.  Whereas the  MN  glyco- 
protein shown is free of detectable contaminants, the MM preparation contains 
one and the NN preparation two minor faster migrating contaminants. Appar- HARTWIG  CLEVE, HIDEO  HAMAGUCHI, THOMAS HUTTEROTH  1145 
ent molecular weights were determined from the migration rates accmding to 
Weber and Osborn (29). The apparent molecular weight of the MN glycopro- 
tein was with this method found to be 58,000 daltons. 
Apparent molecular weights were also estimated from the elution volumes on 
Sepharose 4B-guanidine hydrochloride columns, as described by Fish, Mann, 
and Tanford (30). The column was calibrated with purified polypeptide chains; 
human immunoglobulin G light- and heavy-chains and human haptoglobin 1-1 
a-  and fl-chains were used  (Fig. 4).  The molecular weight of the MN glyco- 
protein estimated from the elution volume was found to be 24,000 daltons. 
Amino acid composition was determined by duplicate analyses of prepara- 
FIG. 3.  Electrophoresis on  1%  SDS-7.5%  acrylamide gels.  Purified MN glycoproteins: 
1-3 stained by Coomassie  brilliant blue; 4-6 stained by PAS reagent.  (1 and 4)  MM glyco- 
protein, (2 and 5) MN glycoprotein, and (3 and 6) NN glycoprotein. 
tions from three different individuals of each of the three genotypes. The results 
from these nine preparations are given in Table II. Significant differences among 
the genotypes MM, MN, and NN were not observed. The content of threonine 
serine, and glutamine is relatively high; the amount of methionine and phenyl- 
alanine is relatively low; half-cysteine residues were not discovered. The amino 
acid  data were  used  to  calculate  the  minimal molecular weight of the  MN 
glycoprotein (23).  The results are given in Fig. 5.  The  amino acid data are 
compatible with three different molecular weights for the peptide part of the 
MN glycoprotein. The molecular weights are 7000, 14,500, and 21,000,  respec- 
tively. Assuming a peptide content of 40 % these values correspond to molecular 
weights of 17,500, 36,250, and 52,000, respectively for the total glycoprotein. In 
Table III the number of amino acid residues per peptide has been calculated for 
the three most compatible molecular weights. The total number of residues was 1146  JaN  GLYCOPROTEINS  OF  HUMAN  ERYTHROCYTE  MEMBRANES 
estimated to be 54,  114, or 164, respectively. The statistical analysis is given by 
the values of Z (DI/R~)  ~ X  10  ~, where the subscript i represents the ith kind of 
amino acid residue. Di is the difference between the analytical composition of an 
amino acid and its nearest integer for a trial molecular weight, and Ri is moles of 
i in 10  ~  g protein. 
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Immunologic  Activities  of MN  Glycoprotein.--The  serologic  activities  of  a 
total of 14 preparations are summarized in Table IV. Purified MM glycoprotein 
inhibits rabbit-anti-M serum at  a  concentration  of approximately 5  #g/ml; if 
very large quantities of MM preparations are employed, 3000 #g/ml, a  rabbit- 
anti-N serum can also be inhibited. Purified NN glycoprotein inhibits a rabbit- 
anti-N serum at a concentration of approximately 20 #g/ml. The rabbit-anti-M 
serum cannot be inhibited by this material. Purified preparations from individ- 
TABLE II 
Amino Acid Composition of MN Glycoproteins* 
Moles % 
MM  MN  NN 
Range  Mean  Range  Mean  Range  Mean 
Lys  4.03-4.72  4.51  3,72-5.07  4.21  3.87-4.54  4.23 
His  3.60-3.79  3.72  3.36-3.97  3.76  3.30-3.89  3.68 
Arg  3.90-4.64  4.29  3,71-4.60  4.21  4.01-4.34  4.20 
Asp  6.12-6.62  6.31  5.85-6.33  6.16  6.11-6.53  6.29 
Thr  9.84-10.48  10.12  10.20-11.04  10.66  10.0-10.79  10.38 
Set  11.78-13.86  12.68  11.85-12.61  12.23  11.30-12.62  11.96 
Glu  10.76-10.97  10.86  9.49-11.01  10.13  11.19-12.06  11.46 
Pro  6.26-7.71  6.89  6.79-8.05  7.40  6.86-7.30  7.08 
Gly  5.49-6.62  6.05  4.58-5.12  4.89  4.65-5.67  4.95 
Ala  4.98-5.31  5.15  4.76-5.27  4.89  4.94-5.45  5.16 
Cys/2  0  0  0  0  0  0 
Val  7.13-8.00  7.58  7.67-8.52  8.07  6.99-8.23  7.92 
Mete:  1.64-2.16  1.8l  1.61-2.15  1.97  1.40-1.63  1.51 
Ile  6.12-7.51  6.66  7.22-7.57  7.47  6.45-7.67  7.29 
Leu  5.13-7.00  5.98  6.32-7.41  6.74  6.64-7.23  6.85 
Tyr  3.68-6.70  5.71  4.24-6.47  5,48  3.59-6.48  5.39 
Phe  1.46-1.88  1.74  1.55-1.88  1,68  1.59.1.94  1.74 
* For each genotype three preparations from three different  individuals were analyzed in 
duplicates.  Hydrolysis in 6 N HC1 fo~ 22 hr at 110°C. 
:~ Met after performic acid oxidation: 2.10 moles per cent  (average  of two preparations 
analyzed in duplicates). 
uals heterozygous for MN require more than twice the quantity of either homo- 
zygous preparation  to  inhibit M-  or N-rabbit  antisera.  Table IV  shows  that 
from the MN preparation approximately 15/~g/ml  are required to inhibit the 
M-, and that approximately 65/zg/ml are necessary to inhibit the N-antiserum. 
From 5.2  to  42.4  t~g/ml  of  the  purified glycoprotein are  necessary to  inhibit 
myxovirus hemagglutination. Significant differences between the MN genotypes 
were  not  observed,  although  the  quantities  required  from  MM  glycoprotein 
tended  to  be  lower.  The  purified  MN  glycoprotein preparations  also  act  as 
potent  inhibitors  for  Phaseolus  vulgaris  phytohemagglutination.  The  specific 
inhibitory activity was found to be approximately 13/xg/ml with  a  relatively 1148  MN  GLYCOPROTEINS  OF HUN[AN  ERYTHROCYTE  MEMBRANES 
narrow  range  from  8.1  to  19.1  #g/ml.  Differences  in inhibitory activities for 
PHA were not observed  for  the  three  genotypes,  MM,  MN,  and  NN.  The 
preparations were also tested for other serologic activities; a total of 15 prepara- 
tions obtained from donors with blood group A  were tested for the presence of 
the A  antigen;  10 preparations were negative for A  antigenic activity. In five 
preparations traces of A  activity could be found. The specific inhibitory activi- 
ties were calculated to be 45, 50, 380, 400, and 1850 t~g/ml, respectively. A total 
TABLE III 
Calculated Number of AA Residues 
Assumed molecular weight  7000  14,500  21,000 
Lys  2.32  2  4.81  5  6.97  7 
His  2.06  2  4.27  4  6.19  6 
Arg  2.31  2  4.78  5  6.92  7 
Asp  3.38  3  6.99  7  10.13  10 
Thr  5.84  6  12.10  12  17.52  18 
Ser  6.71  7  13.89  14  20.12  20 
Glu  5.30  5  10.99  11  15.91  16 
Pro  4.06  4  8.40  8  12.17  12 
Gly  2.84  3  5,89  6  8.53  9 
Ala  2.69  3  5.57  6  8.06  8 
Cys/2  0  0  0  0  0  0 
Val  4.42  4  9.16  9  13.27  13 
Met  1.03  1  2.13  2  3.08  3 
Ile  4.11  4  8.52  9  12.34  12 
Leu  3.70  4  7.66  8  11.09  11 
Tyr  2.98  3  6.18  6  8.95  9 
Phe  0.92  1  1.90  2  2.76  3 
\ed 
Total number of AA residues 
4.80  6.13  6.56 
54  114  164 
Data from duplicate analyses of three MN preparations from  three different  individuals 
were used. 
of  11  preparations were  tested for  the  ability to  inhibit hemagglutination  by 
concanavalin A. All 11  preparations were  found  to  be negative. The  purified 
MN glycoprotein does not appear to possess an active receptor for concanavalin 
A. 
Purified  MN  glycoproteins  were  tested  for  inhibition  of  plant  mitogen- 
induced  lymphocyte stimulation in  vitro. The  results of  12  experiments  with 
the Phaseolus vulgaris mitogen PHA-P  (Difco Laboratories) are given in Fig. 6. 
The  lymphocyte  stimulation  induced  by  a  standard  dose  of  PHA-P  showed 
great  individual  variations.  Stimulation  as  measured  by  thymidine-3H  in- HARTWIG  CLEVE,  HIDEO  tIAMAGUCI-II,  THOMAS  1TUTTEROTtI  1149 
corporation ranged from 13,500 to 250,000  cpm. Addition of MN glycoprotein 
also had very variable effects.  In some experiments, no significant change was 
observed.  In a  few experiments  stimulation  appeared to be enhanced.  In the 
majority of experiments, however, partial inhibition of lymphocyte stimulation 
was found. This inhibitory effect appeared to be dose dependent. The variable 
results  could not be related  to incompatibilities in the MN system; the MN- 
type of lymphocyte donor and  the MN-type of the erythrocyte glycoprotein 
preparation  were  not  responsible  for  the  observed  variation.  When  the  in- 
TABLE IV 
Specific Inhibitory Activities of MN Glycoproteins  from Human Erythrocytes 
PHA-P  Anti-M  Anti-N  Influenza virus 
(Difco)  (rabbit, 7016)  (rabbit, 7148)  RI/5+ 
MM 
A-66839  10.4  5.2  No inhibition  5.2 
A-7551-1  15.8  5.2  No inhibition*  10.6 
-2  19.1  n.t.  n.t.  n.t. 
-3  10.8  4.0  n.t.  10.8 
R-70671  10.6  7.1  No inhibition*  14.2 
MN 
A-77334-1  10.6  7.2  42.4  42.4 
-2  14.7  19.6  78.4  14.8 
A-80922  13.6  13.6  36.2  13.6 
A-82884-1  11.2  21.6  89.2  29.8 
-2  14.2  10.8  85.2  21.2 
NN 
A-75056  14.8  No inhibition  29.6  11.0 
A-79395-1  16.5  No inhibition  24.4  12.4 
-2  8.1  No inhibition  16.2  16.2 
C-62971  11.9  No inhibition  15.8  23.8 
#g/ml completely inhibiting the agglutination of erythrocytes at four hemagglutinating 
doses. 
n.t., not tested. 
* Weak inhibition at 3.0 mg/ml. 
dividual  variation  is  disregarded  and  all  results  are pooled,  average effects 
can be calculated (Fig. 7).  It can be  seen  that  the  addition  of purified  MN 
glycoprotein  results  in  a  partial  inhibition  of  PHA-P-induced  lymphocyte 
stimulation.  At a  MN glycoprotein concentration of 40 #g/ml stimulation  is 
reduced on the average by approximately 45 %. The inhibitory capacity of the 
erythrocyte MN glycoprotein was also tested for the purified Phaseolus vulgaris 
mitogen (Burroughs Wellcome & Co., Inc., Tuckahoe, N. Y.)  (Fig.  8). In these 
experiments  a  standard  dose  of 0.5  #g/ml  PHA-BW induced  stimulation  of 
140,000  to  250,000  cpm. Addition of MN glycoprotein to  a  concentration of 1150  MN  GLYCOPROTEINS  OF HUMAN  ERYTHROCYTE  MEMBRANES 
40 #g/ml did not significantly inhibit PHA-BW-induced stimulation of lympho- 
cytes (Fig. 9). Concanavalin A-induced lymphocyte stimulation was studied in 
four experiments. Addition of MN  glycoprotein up  to  a  concentration of 40 
/zg/ml did not in three out of four experiments inhibit stimulation (Fig. 8). In 
one  experiment partial  inhibition was  observed. The average results did not 
indicate a significant influence of the red cell MN glycoprotein on the lympho- 
cyte stimulation induced by concanavalin A  (Fig. 9). 
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FIC.  6.  Inhibition of lymphocyte stimulation induced by Phaseotus  vulgaris  phytohemag- 
glutinin,  PHA-P  (Difco Laboratories).  50 #g/ml PHA-P were added  to  1 ml cultures with 
0.2  X  106 mononuclear cells isolated from fresh human peripheral blood. Cultures were kept 
for 72 hr. Lymphocyte stimulation was measured by thymidine-3H incorporation into DNA; 
counts per minute are given on  the ordinate.  Results of 12  experiments are given in  three 
groups according to the MN blood group type of the donor of b~nphocytes. On the abscissa 
the concentrations of MN glycoproteins added to the cultures are plotted. The MN type of 
the added glycoproteins are given by  O-.-.-.-Q  for MM,  O ..... O  for MN, and H  for 
NN. 
DISCUSSION 
By extraction of red cell ghosts with a mixture of chloroform and methanol, 
erythrocyte  membrane  glycoproteins  are  solubilized  and  recovered  in  the 
aqueous phase in high yields and uncontaminated with proteins free of carbo- 
hydrate? In  the present study it has been shown that the MN  glycoprotein 
can be prepared from this phase by gel filtration on Sepharose 4B-6 M guanidine 
hydrochloride columns. The purified MN glycoprotein is relatively free from the 
minor  glycoprotein components and,  in  most  preparations,  AB  blood  group 
activities cannot be demonstrated. The procedure may, thus, offer an advantage HARTWIG  CLEVE~  tIIDEO  I-IAMAGUCI-II  7  TtIOMAS  ttUTTEROTI-I  1151 
over  the  widely  employed  phenol  extraction  (see  ref.  10)  and  the  recently 
developed  solubilization  with lithium diiodosalicylate  (31).  It must be pointed 
out, however, that our material contained  appreciable quantities  of lipid. 
Analysis of carbohydrate  and  amino  acid  compositions of the  glycoproteins 
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FIG. 7.  Influence of MN glycoprotein  on the lymphocyte stimulation  induced  by PHA-P 
(Difco Laboratories). Results  from 12 experiments  shown in Fig. 6 are expressed in per cent 
inhibition  and per cent stimulation,  respectively. II  I  is the plot of mean values obtained 
vs. the concentration  of MN glycoprotein added to the cultures. 
from the  three  main  MN  genotypes did  not  reveal significant  differences con- 
firming  previous  reports  (8,  9).  The  apparent  discrepancies  concerning  the 
molecular  weight  of the  MN  glycoprotein  remain  unresolved.  Previous  ultra- 
centrifugal  studies  have  led  to  a  molecular  weight  of  approximately  31,000 
daltons  for the momomeric unit  (4, 5).  More recently,  the  apparent  molecular 
weight  was determined  by SDS-polyacrylamide  gel  electrophoresis  and  found 1152  MN  GLYCOPROTEINS  OF  HUMAN  ERYTHROCYTE  MEMBRANES 
to be 55,000  (32).  The number of amino acid residues was determined to be 
203  (33).  In close  agreement with these results is the value of 58,000  daltons 
obtained by us using the same method. Statistical analysis of the amino acid 
composition~  however, suggests a  lower molecular weight and a  shorter poly- 
peptide chain  (Fig. 5  and Table III). If the value of 203  residues per chain 
proved to be correct, the existence of internal homologies has to be considered. 
It is interesting to note that the determination of the molecular weight from 
the elution volume on a Sepharose 4B column in the presence of 6 ~t guanidine 
hydrochloride leads to the low value of 24,000. Presumably, the elution of this 
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FIG. 8.  Influence of MN glycoprotein on the lymphocyte stimulation induced by purified 
Phaseolus  vulgaris  mitogen  (PHA-BW),  left side of figure,  three experiments,  and by con- 
canavalln A, right side of figure, four experiments. Plot as in Fig.  6. 
protein very rich in carbohydrate is slightly retarded, but the possibility re- 
mains that the values obtained by SDS-acrylamide gel electrophoresis are mis- 
leading and higher than the true molecular weight of this protein. 
Immunologic analysis demonstrated  that in  addition to  the  MN  antigens 
and  the  receptors  for  Vicia  graminea  and  for  myxovirus agglutination  the 
purified MN  glycoprotein also  contained the  receptor  for Phaseolus  vulgaris 
hemagglutination.  The  PHA  receptor  presumably  resides  in  an  oligosac- 
charide side-chain which is structurally different from the oligosaecharide side- 
chain carrying the MN  antigens  00,  26).  Highly purified preparations from 
blood group A donors were free of A activity; the MN glycoprotein also did not 
contain an active concanavalin A receptor. 
The results on the influence of the MN glycoprotein on the PHA-induced HARTWIG  CLEVE,  HIDEO  HAMAGUCHI,  THOMAS  H0TTEROTtI  1153 
lymphocyte stimulation confirm and extend the initial observations of Kornfeld 
and Kornfeld (26,  34). The MN glycoprotein inhibits partially the mitogenic 
activity of unfractionated Phaseolus vulgaris phytohemagglutinin. The purified 
mitogen of Phaseolus  vulgaris  is,  however, not inhibited by addition  of MN 
glycoprotein. These results are in agreement with a  recent report by Titrnvik 
and Carlsson  (35). The most likely interpretation of our results is the assump- 
tion of two different receptor sites on the lymphocyte membrane. One of these 
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FIG. 9. Influence of MN glycoprotein  on the lymphocyte stimulation induced by purified 
Phaseolus vulgaris mitogen (BHA-BW),  and by concanavalin  A. Plot as in Fig. 7. 
receptors reacts with the purified mitogen and is confined to lymphocytes. The 
other receptor responds to another component in unpurified Yhaseolus vulgaris 
preparations.  With  this reaction the purified MN  glycoprotein can interfere, 
either because similar receptors are present on  the red cell MN  glycoprotein 
and on the lymphocyte membrane, or because of binding and inactivation of 
the mitogen by MN glycoprotein at a site different from that reacting with the 
lymphocyte receptor. 
SUMMARY 
Human erythrocyte membrane glycoproteins were solubillzed and recovered 
in the aqueous phasc after extraction of red cell ghosts with a mixture of chloro- 1154  MN  GLYCOPROTEINS  OF  HUMAN  ERYTHROCYTE  ~vIEMBRANES 
form and  methanol.  The major glycoprotein,  the  so-called MN  glycoprotein, 
was prepared from this phase by gel filtration on Sepharose 4B columns in 6 ~ 
guanidine hydrochloride. By SDS-acrylamide gel electrophoresis the MN glyco- 
proteins from the three major genetic types, MM, MN, and NN, were found to 
be relatively free from minor glycoprotein contaminants. The carbohydrate and 
amino acid composition did not reveal significant differences between the three 
MN  genotypes.  The  specific  activities of  the  purified  glycoproteins were de- 
termined for inhibition of agglutinating anti-M and anti-N rabbit antisera and 
for inhibition of myxovirus hemagglutination. It was, furthermore, established 
that  the  purified  MN  glycoproteins contain  a  receptor for Phaseolus  vulgaris 
phytohemagglutination.  The  red  cell  MN  glycoprotein  inhibits  partially 
lymphocyte stimulation  induced  by unfractionated  Phaseolus  vulgaris  phyto- 
hemagglutinin; the red cell MN glycoprotein does not influence the lymphocyte 
stimulation induced  by purified Phaseolus  vulgaris  mitogen. 
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